Manikay Partners’s Audentes Therapeutics BOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-400,000
Closed -$23.9M – 21
2019
Q4
$23.9M Buy
+400,000
New +$15M 2.68% 11

Manikay Partners's BOLD Position: Q1 2020 in Review

Manikay Partners sold out of Audentes Therapeutics (BOLD) in Q1 2020, closing a stake of 400,000 shares — an estimated $23.9M sold.

Manikay Partners first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $23.9M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Manikay Partners reported no remaining Audentes Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Manikay Partners sold 400,000 Audentes Therapeutics shares in Q1 2020, an estimated $23.9M.
  • Manikay Partners first reported a position in Audentes Therapeutics in Q4 2019 and held it in 1 quarter.
  • Manikay Partners's Audentes Therapeutics position peaked at $23.9M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics as of Q1 2020.

Based on Manikay Partners's 13F filing for Q1 2020.